ATLEE FRANK V III 4
4 · ANTIGENICS INC /DE/ · Filed Jan 18, 2005
Insider Transaction Report
Form 4
ATLEE FRANK V III
Director
Transactions
- Award
Deferred Shares
2005-01-14$8.63/sh+5,214.368$45,000→ 50,214.368 total→ Common Stock (5,214.368 underlying)
Footnotes (1)
- [F1]Acquired under the terms of the Antigenics Inc. Director's Deferred Compensation Plan. Deferred shares represent an equal number of shares of the Company's common stock to be distributed in accordance with the terms of the Plan, typically after the director ceases to serve as a director of the Company.